GlassScriptPhysician profile
Khaled Mahlies
NPI 1497720585
$4,092.38
in general payments reported to CMS, 2019-2025
16 companies · $309 in 2025
The $309 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,319 · 2020: $846 · 2021: $658 · 2022: $731 · 2023: $230 · 2025: $309.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $539.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $539.10 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $900.08 | 2019-2022 | |
| Astrazeneca Pharmaceuticals LP | $619.86 | 2020-2023 | Farxiga |
| Boehringer Ingelheim Pharmaceuticals, INC. | $551.86 | 2021-2023 | Jardiance |
| Organogenesis INC. | $542.06 | 2019-2022 | |
| Esperion Therapeutics, INC. | $373.78 | 2020-2022 | |
| Olympus America INC. | $309.16 | 2025 | Itind System |
| Novartis Pharmaceuticals Corporation | $194.31 | 2019-2022 | |
| Kci USA, INC. | $192.34 | 2019 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $132.89 | 2021 | |
| Abbvie INC. | $73.76 | 2020-2021 | |
| Boston Scientific Corporation | $69.85 | 2019 | |
| Misonix INC | $48.45 | 2020-2021 | |
| Tetraphase Pharmaceuticals, INC. | $47.54 | 2019 | |
| Paratek Pharmaceuticals, INC. | $12.79 | 2020 | |
| Abbott Laboratories | $12.38 | 2022 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nestle Healthcare Nutrition INC. | $11.27 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Khaled Mahlies listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.